🇩🇰 Denmark · Prosthetics and orthotics
Embla100Integrity
Sveinn SölvasonPresident & CEO, Embla MedicalPromisedSales growth, 20265–8%3 February 2026↗
Sveinn SölvasonPresident & CEO, Embla MedicalPromisedSales growth, 20265–8%3 February 2026↗🇩🇰 Denmark · Prosthetics and orthotics
Embla90Integrity
Sveinn SölvasonPresident & CEO, Embla MedicalPartly keptSales growth, 20265–8%about 5%20 October 2026↗ · provisionalSeverity: major · −10 points
Sveinn SölvasonPresident & CEO, Embla MedicalPartly keptSales growth, 20265–8%about 5%20 October 2026↗ · provisionalSeverity: major · −10 points🇩🇰 Denmark · Prosthetics and orthotics
Embla90Integrity
Sveinn SölvasonPresident & CEO, Embla Medical
Sveinn SölvasonPresident & CEO, Embla MedicalWill Sveinn Sölvason keep his new promise for Embla?
The new promiseAbout 5% more sales in 2026.
Max Noble Odds: 55% chance he keeps it. They move with every call. Against the odds you win more, and lose more.
The small print, in plain words
- He promised
- 5–8% more sales
- He got
- About 5%
- Why, says the company
- Its clinics sold less than planned, and it lost a contract in Sweden. The profit promise held.
- How bad
- Major. Only the bottom of the promise, after three cuts. Score 100 → 90.
Read the promise ↗︎Q4 and full-year 2025 report, ann. 5/2026, p. 1Read the result ↗︎Interim report Q3 2026, ann. 51/2026, p. 1 and p. 7